Apixaban exposure and anti-Xa activity in nonvalvular atrial fibrillation patients: an application of population PK/PD analysis - Kowalski, K; Nielsen, J; Roy, A (J Pharmacokinet Pharmacodyn, 2014)
(Abstract M-027).